Subscribe To
Viatris (vtrs) gets fda nod for generic drug in dry eye disease
Viatris' (VTRS) subsidiary is the first to receive approval from the FDA to market a generic version of AbbVie's Re...
February 4, 2022, 1:45 pm
Viatris (vtrs) gets fda nod for generic drug in dry eye disease
Viatris' (VTRS) subsidiary is the first to receive approval from the FDA to market a generic version of AbbVie's Re...
February 4, 2022, 1:45 pm
Kaleido biosciences to present updated data of kb295 in ulcerative colitis at the 2022 crohn's and colitis congress
LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, ...
January 21, 2022, 11:04 am
Kaleido biosciences to present updated data of kb295 in ulcerative colitis at the 2022 crohn's and colitis congress
LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, ...
January 21, 2022, 11:04 am
Kaleido biosciences to present updated data of kb295 in ulcerative colitis at the 2022 crohn's and colitis congress
LEXINGTON, Mass., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage biotech company with a differentiated, ...
January 21, 2022, 11:04 am
Here's why you should retain haemonetics (hae) stock for now
Investors are optimistic about Haemonetics (HAE) on strong demand for NexSys PCS system and potential of Hemos...
October 6, 2021, 10:30 am
Here's why you should retain haemonetics (hae) stock for now
Investors are optimistic about Haemonetics (HAE) on strong demand for NexSys PCS system and potential of Hemos...
October 6, 2021, 10:30 am
Here's why you should retain haemonetics (hae) stock for now
Investors are optimistic about Haemonetics (HAE) on strong demand for NexSys PCS system and potential of Hemos...
October 6, 2021, 10:30 am
Statera biopharma, inc. to participate in the a.g.p. biotech and specialty pharma conference
FORT COLLINS, Colo., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-gener...
October 6, 2021, 7:33 am
Statera biopharma, inc. to participate in the a.g.p. biotech and specialty pharma conference
FORT COLLINS, Colo., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-gener...
October 6, 2021, 7:33 am
Statera biopharma, inc. to participate in the a.g.p. biotech and specialty pharma conference
FORT COLLINS, Colo., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (Nasdaq: STAB), a leading biopharmaceutical company creating next-gener...
October 6, 2021, 7:33 am